Mar 09, 2022 / 03:15PM GMT
Unidentified Participant
Good morning, everyone. I'd like to introduce Philip Young, CEO of Lobe Sciences. He will be presenting for 30 minutes and perhaps taking questions at the end of his presentation. Philip, take it away.
Philip Young - Lobe Sciences Ltd. - CEO & Director
Thank you, Nelsa. And thanks for joining us and I look forward to some questions at the end. And thanks to the Investor Summit for putting the conference on. What I'd like to do is review where Lobe has been and where Lobe is headed to in 2022.
We've got really exciting plans this year for growing the company, taking the next steps to being really a fully integrated biotech company, developing therapeutics. But before we go there, I have to let you know that -- excuse me, that I'll be making some forward-looking statements. And that all of our filings are current on SEDAR and please feel free to read them for any clarifications.
So who's Lobe and what are we doing today? Well, we're a biotech company that's developing and delivering therapeutics to improve the human condition
Lobe Sciences Ltd at Q1 Virtual Investor Summit Transcript
Mar 09, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers